LPCN

Conviction 18HealthcareScan · Fri, Jun 26, 2026

LPCN$2.49+4.62%

ResistanceSupportVol 14

Vol MA14 121.64K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Lipocine Inc.PHARMACEUTICAL PREPARATIONSwww.lipocine.com ↗

Price2.49

Change+4.62%

Gap+0.00%

Rel volume0.49×

Avg volume114.91K

Avg $ vol259.63K

SMA 202.26

SMA 502.30

SMA 2004.67

Price vs 50+8.32%

Price vs 200-46.66%

MA stackmixed

50/200 cross—

Supertrendup · 1.97

RSI (14)56

MACD hist0.06

MACD cross—

Stoch %K / %D75 / 70

ADX (14)25

+DI / −DI22 / 13

RSI divergence—

MACD divergenceBearish

ATR %+7.11%

ADR %7.10%

52w high11.26

52w low1.94

From 52w high-77.89%

Above 52w low+28.35%

New 52w highNo

SqueezeOff

Bollinger width25.83%

%B0.90

Donchian pos75.46%

Donchian high2.67

Donchian low1.94

AVWAP (52w high)3.53

vs AVWAP high-29.43%

AVWAP (52w low)2.14

vs AVWAP low+16.56%

OBV trendUp

Chaikin MF (20)0.01

Today vs 20d0.49×

Avg vol (14d)121.64K

Avg vol (20d)114.91K

Avg $ vol (20d)259.63K

Market cap—

RS 3m (vs SPY)-79.76%

RS 6m (vs SPY)-51.36%

RS line new highNo

Trend template2/8

Technical rank33.6

1 week+6.87%

1 month+9.21%

3 months-66.35%

6 months-45.99%

1 year-22.91%

YTD-68.87%

P/E-2.05

P/B0.86

P/S39.41

P/FCF-2.00

EPS-1.69

Div yield—

ROE-42.17%

ROA-37.97%

Debt/Eq0.13

Current9.99

EV/EBITDA-1.71

Gross margin—

Net margin—

Rev growth-96.90%

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value17.61M

Revenue54.99K

Net income-3.67M

Gross profit—

Free cash flow-9.85M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees14

ListedTue, Jun 5, 2012

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank33.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.61

Support2.03

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LPCN

All disclosures →

No recent disclosed trades by Congress in LPCN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LPCN · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Jene Jill M. Director · Stock Option (Right to Buy) · 2026-06-03	Grant	1.76K	$4K	2026-06-03	2026-06-04
Higuchi John W. Director · Common Stock (Right to Buy) · 2026-06-03	Grant	1.76K	$4K	2026-06-03	2026-06-04
Ono Richard Dana Director · Common Stock (Right to Buy) · 2026-06-03	Grant	1.76K	$4K	2026-06-03	2026-06-04

SEC filings

EDGAR filings in LPCN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.